Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.

Seth G, Sundaresh A, Mariaselvam CM, Kumar G, Chengappa KG, Adarsh MB, Tamouza R, Negi VS.

Lupus. 2020 Feb 27:961203320908940. doi: 10.1177/0961203320908940. [Epub ahead of print]

PMID:
32106787
2.

Letter to the Editor: An Indian Perspective on Universal Open Access Publishing: Think of the Fire before Venturing Out of the Frying Pan!

Misra DP, Ravindran V, Sharma A, Wakhlu A, Ahmed S, Negi VS, Agarwal V.

J Korean Med Sci. 2020 Mar 2;35(8):e85. doi: 10.3346/jkms.2020.35.e85. No abstract available.

3.

Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.

Muralidharan N, Sundaram R, Kodidela S, Chengappa KG, Mariaselvam CM, Misra DP, Negi VS.

Pharmacogenomics J. 2020 Apr;20(2):342-349. doi: 10.1038/s41397-019-0097-x. Epub 2019 Oct 14. Review.

PMID:
31611592
4.

Physicians Perception of Rheumatology Practice and Training in India.

Misra DP, Ravindran V, Sharma A, Wakhlu A, Negi VS, Chaturvedi V, Agarwal V.

J Assoc Physicians India. 2019 Jul;67(7):38-43.

PMID:
31559767
5.

Assessment of Normative Range and Deriving Cut-Off Values for Lupus Anticoagulant Testing: An Experience from a Tertiary Care Center in Southern India.

Ramaraj A, Negi VS, Kar R.

Indian J Hematol Blood Transfus. 2019 Jul;35(3):485-488. doi: 10.1007/s12288-019-01079-9. Epub 2019 Jan 25.

PMID:
31388261
6.

Comment on: 2018 APLAR axial spondyloarthritis treatment recommendations - Need for greater cognizance of regional needs?

Misra DP, Wakhlu A, Sharma A, Negi VS, Agarwal V, Chaturvedi V.

Int J Rheum Dis. 2019 Jul;22(7):1340-1341. doi: 10.1111/1756-185X.13613. No abstract available.

PMID:
31328407
7.

Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis.

Michael BNR, Kommoju V, Kavadichanda Ganapathy C, Negi VS.

Rheumatol Int. 2019 Aug;39(8):1377-1387. doi: 10.1007/s00296-019-04337-1. Epub 2019 Jun 14.

PMID:
31201512
8.

Early Onset Pre-Eclampsia with Nephrotic Range Proteinuria as the Initial Manifestation of Lupus Nephritis: Report of three cases.

Udupa V, Keepanasseril A, Vijayan N, Basu D, Negi VS.

Sultan Qaboos Univ Med J. 2019 Feb;19(1):e73-e76. doi: 10.18295/squmj.2019.19.01.014. Epub 2019 May 30.

9.

SLE-DAS: ready for routine use?

Mathew A, Chengappa KG, Shah S, Negi VS.

Ann Rheum Dis. 2019 May 24. pii: annrheumdis-2019-215704. doi: 10.1136/annrheumdis-2019-215704. [Epub ahead of print] No abstract available.

PMID:
31126954
10.

Clinical correlates of HLA-B*27 and its subtypes in enthesitis-related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients.

Kavadichanda CG, Seth G, Kumar G, Gulati R, Negi VS.

Int J Rheum Dis. 2019 Jul;22(7):1289-1296. doi: 10.1111/1756-185X.13551. Epub 2019 Mar 18.

PMID:
30884197
11.

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study.

Sundaresh A, Oliveira J, Chinnadurai RK, Rajkumar RP, Hani L, Krishnamoorthy R, Leboyer M, Negi VS, Tamouza R.

Heliyon. 2019 Jan 7;5(1):e01124. doi: 10.1016/j.heliyon.2019.e01124. eCollection 2019 Jan.

12.

Persistent eosinophilia in rheumatoid arthritis: a prospective observational study.

Emmanuel D, Parija SC, Jain A, Misra DP, Kar R, Negi VS.

Rheumatol Int. 2019 Feb;39(2):245-253. doi: 10.1007/s00296-018-4191-1. Epub 2018 Nov 13.

PMID:
30426234
13.

Arthritis in sarcoidosis: A multicentric study from India.

Arthritis in Sarcoidosis Group (ASG), Agarwal V, Agrawal V, Aggarwal A, Aggarwal P, Chowdhury AC, Ghosh P, Jain A, Lawrence A, Misra DP, Misra R, Mohapatra MM, Nath A, Negi VS, Pandya S, Reddy VV, Prasad S, Sharma A, Shobha V, Singh YP, Tripathy SR, Wakhlu A.

Int J Rheum Dis. 2018 Sep;21(9):1728-1733. doi: 10.1111/1756-185X.13349. Epub 2018 Sep 5.

PMID:
30187668
14.

The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India.

Devaraju P, Mehra S, Gulati R, Antony PT, Jain VK, Misra DP, Negi VS.

Indian J Med Res. 2018 Jun;147(6):560-566. doi: 10.4103/ijmr.IJMR_2025_16.

15.

Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis.

Shah S, Kavadichanda CG, Belani P, Ganesh RN, Negi VS.

Int J Rheum Dis. 2019 May;22(5):946-950. doi: 10.1111/1756-185X.13365. Epub 2018 Aug 30.

PMID:
30168270
16.

Renal involvement in primary Sjogren's syndrome: a prospective cohort study.

Jain A, Srinivas BH, Emmanuel D, Jain VK, Parameshwaran S, Negi VS.

Rheumatol Int. 2018 Dec;38(12):2251-2262. doi: 10.1007/s00296-018-4118-x. Epub 2018 Aug 23.

PMID:
30155666
17.

Can we further SPARkle the SPAR model?

Kavadichanda CG, Negi VS.

Ann Rheum Dis. 2019 Sep;78(9):e93. doi: 10.1136/annrheumdis-2018-213954. Epub 2018 Jun 29. No abstract available.

PMID:
29959182
18.

Lupus retinopathy: a marker of active systemic lupus erythematosus.

Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, Kumar G, Negi VS.

Rheumatol Int. 2018 Aug;38(8):1495-1501. doi: 10.1007/s00296-018-4083-4. Epub 2018 Jun 13.

PMID:
29948002
19.

The HLA-G Genetic Contribution to Bipolar Disorder: A Trans-Ethnic Replication.

Sundaresh A, Wu CL, Chinnadurai RK, Rajkumar RP, Mariaselvam CM, LeMaoult J, Krishnamoorthy R, Leboyer M, Negi VS, Tamouza R.

Immunol Invest. 2018 Aug;47(6):593-604. doi: 10.1080/08820139.2018.1469649. Epub 2018 May 8.

PMID:
29737889
20.

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

João C, Negi VS, Kazatchkine MD, Bayry J, Kaveri SV.

J Immunol. 2018 Mar 15;200(6):1957-1963. doi: 10.4049/jimmunol.1701271. Review.

21.

Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.

Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS.

Rheumatol Int. 2018 Apr;38(4):557-568. doi: 10.1007/s00296-018-3995-3. Epub 2018 Feb 15.

PMID:
29450636
22.

Better understanding of publishing practices and indexing of target journals is essential.

Misra DP, Ravindran V, Wakhlu A, Sharma A, Agarwal V, Negi VS.

Rheumatol Int. 2018 Feb;38(2):317-318. doi: 10.1007/s00296-017-3897-9. Epub 2017 Dec 1. No abstract available.

PMID:
29196801
23.

Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes.

Jain A, Misra DP, Sharma A, Wakhlu A, Agarwal V, Negi VS.

Rheumatol Int. 2018 Jan;38(1):13-24. doi: 10.1007/s00296-017-3839-6. Epub 2017 Oct 14. Review.

PMID:
29032440
24.

Publishing in black and white: the relevance of listing of scientific journals.

Misra DP, Ravindran V, Wakhlu A, Sharma A, Agarwal V, Negi VS.

Rheumatol Int. 2017 Nov;37(11):1773-1778. doi: 10.1007/s00296-017-3830-2. Epub 2017 Oct 5. Review.

PMID:
28983732
25.

Plagiarism: a Viewpoint from India.

Misra DP, Ravindran V, Wakhlu A, Sharma A, Agarwal V, Negi VS.

J Korean Med Sci. 2017 Nov;32(11):1734-1735. doi: 10.3346/jkms.2017.32.11.1734. No abstract available.

26.

Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.

Jain VK, Bhashini N, Balajee LK, Sistla S, Parija SC, Negi VS.

Indian J Med Res. 2017 Apr;145(4):464-470. doi: 10.4103/ijmr.IJMR_920_15.

27.

Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients.

Muralidharan N, Gulati R, Misra DP, Negi VS.

Clin Exp Med. 2018 Feb;18(1):101-107. doi: 10.1007/s10238-017-0469-y. Epub 2017 Aug 18.

PMID:
28821984
28.

Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.

Mariaselvam CM, Boukouaci W, Charron D, Krishnamoorthy R, Tamouza R, Misra DP, Negi VS.

Int J Rheum Dis. 2018 Mar;21(3):656-663. doi: 10.1111/1756-185X.13138. Epub 2017 Jul 27.

PMID:
28752674
29.

The Serological and Biochemical Markers of Adrenal Cortex and Endocrine Pancreas Dysfunction in Patients with Hashimoto's Thyroiditis: A Hospital-based Pilot Study.

Sahoo JP, Selviambigapathy J, Kamalanathan S, Negi VS, Sridhar MG, Kar SS, Vivekanandan M.

Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):540-544. doi: 10.4103/ijem.IJEM_72_17.

30.

Letter to the Editor: Appropriate Statistical Analysis and Research Reporting.

Misra DP, Wakhlu A, Agarwal V, Sharma A, Negi VS.

J Korean Med Sci. 2017 Aug;32(8):1379-1380. doi: 10.3346/jkms.2017.32.8.1379. No abstract available.

31.

Profile of Helminthic Infections in Patients Attending a Tertiary Care Hospital with Emphasis on Immunocompromised Patients.

Kandasamy V, Rajkumari N, Parija SC, Chinnakali P, Negi VS.

J Glob Infect Dis. 2017 Apr-Jun;9(2):87-89. doi: 10.4103/jgid.jgid_174_16. No abstract available.

32.

Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis.

Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS.

Eur J Clin Pharmacol. 2017 Aug;73(8):965-971. doi: 10.1007/s00228-017-2255-x. Epub 2017 Apr 25.

PMID:
28444425
33.

Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils.

Negi VS, Mariaselvam CM, Misra DP, Muralidharan N, Fortier C, Charron D, Krishnamoorthy R, Tamouza R.

Int J Immunogenet. 2017 Jun;44(3):114-121. doi: 10.1111/iji.12315. Epub 2017 Apr 4.

PMID:
28374504
34.

Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.

Muralidharan N, Misra DP, Jain VK, Negi VS.

Clin Rheumatol. 2017 Jun;36(6):1253-1259. doi: 10.1007/s10067-017-3608-7. Epub 2017 Mar 27.

PMID:
28349270
35.

2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?

Misra DP, Agarwal V, Sharma A, Wakhlu A, Negi VS.

Ann Rheum Dis. 2017 Nov;76(11):e47. doi: 10.1136/annrheumdis-2017-211446. Epub 2017 Mar 27. No abstract available.

PMID:
28347992
36.

Interferon targeted therapies in systemic lupus erythematosus.

Misra DP, Negi VS.

Mediterr J Rheumatol. 2017 Mar 28;28(1):13-19. doi: 10.31138/mjr.28.1.13. eCollection 2017 Mar. Review.

37.

An exploratory study of immune markers in acute and transient psychosis.

Mahadevan J, Sundaresh A, Rajkumar RP, Muthuramalingam A, Menon V, Negi VS, Sridhar MG.

Asian J Psychiatr. 2017 Feb;25:219-223. doi: 10.1016/j.ajp.2016.11.010. Epub 2016 Dec 1.

PMID:
28262155
38.

Talonavicular and Naviculocuneiform Joint Involvement in Diffuse Idiopathic Skeletal Hyperostosis.

Misra DP, Chengappa KG, Jain VK, Negi VS.

J Clin Rheumatol. 2017 Mar;23(2):119. doi: 10.1097/RHU.0000000000000507. No abstract available.

PMID:
28225515
39.

Genpolymorphismen proinflammatorischer Zytokine aus Th1-Zellen und das Psoriasisrisiko in einer südindischen tamilischen Kohorte.

Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS.

J Dtsch Dermatol Ges. 2017 Feb;15(2):208-211. doi: 10.1111/ddg.13043_g. No abstract available.

PMID:
28214319
40.

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.

Pellegrini L, Xue J, Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, Bianchi ME, Morris P, Pass HI, Gaudino G, Carbone M, Yang H.

Oncotarget. 2017 Apr 4;8(14):22649-22661. doi: 10.18632/oncotarget.15152.

41.

Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.

Aggarwal A, Gupta R, Negi VS, Rajasekhar L, Misra R, Singh P, Chaturvedi V, Sinha S.

Clin Exp Immunol. 2017 May;188(2):254-262. doi: 10.1111/cei.12930. Epub 2017 Feb 23.

42.

Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus.

Negi VS, Devaraju P, Misra DP, Jain VK, Usdadiya JB, Antony PT, Gulati R.

Clin Rheumatol. 2017 Apr;36(4):837-843. doi: 10.1007/s10067-017-3539-3. Epub 2017 Jan 17.

PMID:
28097447
43.

Tuberculosis mimicking primary systemic vasculitis: not to be missed!

Jain A, Misra DP, Ramesh A, Basu D, Jain VK, Negi VS.

Trop Doct. 2017 Apr;47(2):158-164. doi: 10.1177/0049475516687432. Epub 2017 Jan 16.

PMID:
28092221
44.

Polymorphisms in T helper 1 proinflammatory cytokine genes and the risk of psoriasis in a South Indian Tamil cohort.

Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS.

J Dtsch Dermatol Ges. 2017 Feb;15(2):208-211. doi: 10.1111/ddg.13043. Epub 2017 Jan 13. No abstract available.

PMID:
28084669
45.

T helper-2 cytokine/regulatory T-cell gene polymorphisms and their relation with risk of psoriasis in a South Indian Tamil cohort.

Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS.

Hum Immunol. 2017 Feb;78(2):209-215. doi: 10.1016/j.humimm.2016.12.006. Epub 2016 Dec 24.

PMID:
28027921
46.

Sarcoidosis, neurotoxoplasmosis and golimumab therapy.

Misra DP, Chengappa KG, Mahadevan A, Jain VK, Negi VS.

QJM. 2016 Dec;109(12):817-818. doi: 10.1093/qjmed/hcw197. Epub 2016 Dec 22. No abstract available.

PMID:
28011850
47.

A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis.

Misra DP, Sharma A, Kadhiravan T, Negi VS.

Autoimmun Rev. 2017 Feb;16(2):179-191. doi: 10.1016/j.autrev.2016.12.009. Epub 2016 Dec 15. Review.

PMID:
27988436
48.

Letter to the Editor: Predatory Practices and How to Circumvent Them: a Viewpoint from India.

Ravindran V, Misra DP, Negi VS.

J Korean Med Sci. 2017 Jan;32(1):160-161. doi: 10.3346/jkms.2017.32.1.160. No abstract available.

49.

Takayasu arteritis (TA) first presenting with intestinal ischemia: a case report and review of gastrointestinal tract involvement (ischemic and non-ischemic) associated with TA.

Misra DP, Krishnan N, Gochhait D, Emmanuel D, Negi VS.

Rheumatol Int. 2017 Jan;37(1):169-175. doi: 10.1007/s00296-016-3600-6. Epub 2016 Nov 10. Review.

PMID:
27832292
50.

Effect of Fluoxetine on Inflammatory Cytokines in Drug-Naive Major Depression: A Short-Term Prospective Study from South India.

Muthuramalingam A, Menon V, Rajkumar RP, Negi VS.

J Clin Psychopharmacol. 2016 Dec;36(6):726-728. No abstract available.

PMID:
27753707

Supplemental Content

Support Center